Javier J. Rodriguez
Chief Executive Officer, DaVita Inc.
Mr. Rodriguez joined our Board in June 2020. Mr. Rodriguez is the Chief Executive Officer of DaVita Inc., a Fortune 500 company providing healthcare services to kidney disease patients throughout 12 countries. He assumed his current role with DaVita in 2019, building on his more than 20 years of increasing company leadership and commitment to transforming care delivery for patients with kidney disease – from the earliest stages through transplantation. From 2014 to 2019, he was the CEO of DaVita Kidney Care, the company’s business unit that treats patients with kidney failure and end-stage renal disease. Mr. Rodriguez is recognized for his vision and leadership in transforming how kidney care is delivered and accelerating the digital transformation to improve patients’ lives while lowering costs for the health care system. He currently serves on the board of directors of DaVita.
-
Daniel O’Day
Chairman and Chief Executive Officer
-
Jacqueline K. Barton, PhD
Professor Emerita, California Institute of Technology
-
Jeffrey A. Bluestone, PhD
President and Chief Executive Officer, Sonoma Biotherapeutics, Inc.
-
Sandra J. Horning, MD
Retired Chief Medical Officer, Roche, Inc.
-
Kelly A. Kramer
Retired Chief Financial Officer, Cisco Systems, Inc.
-
Ted W. Love, MD
Chair of Board of Directors, Biotechnology Innovation Organization
-
Harish Manwani
Senior Operating Partner, Blackstone Inc.
-
Javier J. Rodriguez
Chief Executive Officer, DaVita Inc.
-
Anthony Welters
Lead Independent Director; Chairman and Chief Executive Officer, CINQ Care